Cardiology

Coronary Care

Rescue Coronary Angiography after Failed Thrombolysis: A Real-Life Experience

Gruberg L. · Di Segni E. · Agranat O. · Har Zahav Y. · Freimark D. · Kaplinsky E. · Hod H.

Author affiliations

The Heart Institute, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel

Related Articles for ""

Cardiology 1998;90:48–51

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Coronary Care

Published online: August 14, 1998
Issue release date: July 1998

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)

For additional information: https://www.karger.com/CRD

Abstract

Failed thrombolysis in acute myocardial infarction (AMI) patients is associated with a high risk of morbidity and mortality. Rescue or salvage percutaneous transluminal coronary angioplasty (PTCA) in this group of patients is still controversial. We report our experience with early emergency angiography and rescue PTCA in 27 patients who were hemodynamically unstable or had a large area of myocardium at risk after failed thrombolysis. Rescue PTCA was successful in 95% of attempted PTCA. Three patients were referred to emergency CABG. Early ‘rescue angiography’ with or without rescue PTCA after failed thrombolysis in a selected patient population, is an important tool for early risk stratification and decision-making during the hyperacute phase of AMI, while it may also serve in restoring coronary artery patency of the infarct-related artery with a high success rate.




Related Articles:


References

  1. Kim CB, Braunwald E: Potential benefits of late reperfusion of infarcted myocardium. Circulation 1993;88:2426–2436.
  2. The Gusto Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993;329:1615–1622.
  3. Chesebro J, Knatterud G, Roberts R, Borer J, Cohen L, Dalen J, Dodge H, Francis C, Hillis D, Ludbrook P, Markis J, Mueller H, Passamani E, Powers E, Rao A, Robertson T, Ross A, Ryan T, Sobel B, Willerson J, Williams D, Zaret B, Braunwald E: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge. Circulation 1987;76:142–154.
  4. McKendall G, Attubato M, Drew T, Feit F, Sharaf B, Thomas E, Teichman S, McDonald M, Williams D: Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either pre-hospital or in-hospital administration. J Am Coll Cardiol 1991;18:1774–1778.
  5. Laster SB, O’Keefe JH, Giboons RJ: Incidence and importance of thrombolysis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;78:623–626.
  6. White HD, Norris R, Brown MA, Brandt PWT, Whitlock RML, Wild CJ: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44–51.
  7. Sheehan FH, Doerr R, Schmidt WG, Bolson EL, Uebis R, von Essen R: Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant for survival. J Am Coll Cardiol 1988;12:289–300.
  8. Volpi A, Cavalli A, Santoro E, Tognoni G, and the GISSI Investigators: Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction: Evidence for a protective effect of thrombolytic therapy. Circulation 1990;82:1279–1288.
  9. Holmes DR, Gersh BJ, Bailey KR, Reeder GS, Bresnahan JF, Bresnahan DR, Vlietstra RE: Emergency ‘rescue’ percutaneous transluminal coronary angioplasty after failed thrombolysis with streptokinase. Early and late results. Circulation 1990;81(suppl IV):51–56.
  10. Ellis SG, da Silva ER, Heyndrickx G, Talley D, Cernigliaro C, Steg G, Spaulding C, Nobuyoshi M, Erbel R, Vassanelli C, Topol E, for the RESCUE Investigators: Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994;90:2280–2284.
  11. McKendall GR, Forman S, Sopko G, Braunwald E, Williams DO, and the Thrombolysis in Myocardial Infarction Investigators: Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995;76:1108–1111.
  12. Gorfinkel HJ, Berger SM, Klaus AP, Barresi V, Shah MR, Graham B, Arn AR, Guinn VL, Philips M: Rescue angioplasty in failed thrombolysis in acute myocardial infarction: A community hospital experience. J Invas Cardiol 1997;9:83–87.
    External Resources
  13. Shah PK, Cercek B, Lew AS, Ganz W: Angiographic validation of bedside markers of reperfusion. J Am Coll Cardiol 1993;21:55–61.
  14. AHA/ACC Taskforce Report: Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and therapeutic procedures. J Am Coll Cardiol 1993;22:2033–2054.
  15. Rentrop PK: Thrombolytic therapy in patients with acute myocardial infarction. Circulation 1985;71:627–631.
    External Resources
  16. GISSI: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397–402.
  17. Granger CB, Califf RM, Topol EJ: Thrombolytic therapy for acute myocardial infarction. A review. Drugs 1992;44:293–325.
  18. The GUSTO Angiographic Investigators: The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival, after acute myocardial infarction. N Engl J Med 1993;329:1615–1622.
  19. Simoons ML, Betriu A, Col J, von Essen R, Lubsen J, Michel PL, Rutsch W, Schmidt W, Thery C, Vahanian A, Willems GM, Arnold AER, deBono DP, Dougherty FC, Lambertz H, Meier B, Raynaud P, Sanz GA, Serruys PW, Uebis R, Van de Werf F, Wood D: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;i:197–203.
  20. The TIMI Research Group: Immediate vs. delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI IIA results. JAMA 1988;260:2849–2858.
  21. Ganz W: The quest for the ideal reperfusion strategy continues. Circulation 1991;83:1818–1821.
  22. Zijlstra F: Primary angioplasty is the most effective treatment for an acute myocardial infarction. Br Heart J 1995;73:403–404.
  23. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L, Wall TC, Phillips HR III, Abbottsmith CW, Candela RJ, Flanagan WH, Sasahara AA, Mantell SJ, Lee KL, for the TAMI Study Group: Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction Phase 5 randomized trial. Circulation 1985;83:1543–1556.
  24. Gibson MC, Cannon CP, Greene RM, Sequeira RF, Margorien RD, Leya F, Diver DJ, Baim DS, Braunwald E, for the TIMI 4 Study Group: Rescue Angioplasty in the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial. Am J Cardiol 1997;80:21–26.
  25. The CORAMI Study Group: Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol 1994;74:172–174.
  26. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K: Intraaortic balloon pumping as adjunctive therapy to rescue coronary angioplasty after failed thrombolysis in anterior wall acute myocardial infarction. Am J Cardiol 1995;76:73–75.
  27. Barsness GW, Ohman EM, Thompson TD, Sketch MH Jr, Holmes DR Jr, Califf RM: Early hazards of ‘rescue’ angioplasty after thrombolysis is reduced by improved long-term outcome. J Am Coll Cardiol 1997;29(suppl A):71A.
  28. Belenkie I, Traboulsi M, Hall CA, Hansen JL, Roth DL, Manyari D, Filipchuck NG, Schnurr LP, Rosenal TW, Smith ER, Knudson ML: Rescue angioplasty during myocardial infarction has a benefit effect on mortality: A tenable hypothesis. Can J Cardiol 1992;8:357–362.

Article / Publication Details

First-Page Preview
Abstract of Coronary Care

Published online: August 14, 1998
Issue release date: July 1998

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6312 (Print)
eISSN: 1421-9751 (Online)

For additional information: https://www.karger.com/CRD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP